292 related articles for article (PubMed ID: 16772707)
1. Double-blind study of OM-85 in patients with chronic bronchitis or mild chronic obstructive pulmonary disease.
Solèr M; Mütterlein R; Cozma G;
Respiration; 2007; 74(1):26-32. PubMed ID: 16772707
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of OM-85 in Patients with Chronic Bronchitis and/or Chronic Obstructive Pulmonary Disease.
Tang H; Fang Z; Saborío GP; Xiu Q
Lung; 2015 Aug; 193(4):513-9. PubMed ID: 26044556
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of a bacterial extract against acute exacerbation in patients with chronic bronchitis accompanied by chronic obstructive pulmonary disease.
Li J; Zheng JP; Yuan JP; Zeng GQ; Zhong NS; Lin CY
Chin Med J (Engl); 2004 Jun; 117(6):828-34. PubMed ID: 15198881
[TBL] [Abstract][Full Text] [Related]
4. [Preventive effect of an immunomodulator, OM-85 BV, on acute exacerbations of chronic bronchitis in elderly patients. Preliminary results at six months in 291 patients].
Orcel B; Delclaux B; Baud M; Derenne JP
Rev Mal Respir; 1993; 10(1):23-8. PubMed ID: 8451491
[TBL] [Abstract][Full Text] [Related]
5. Identifying patients at risk of late recovery (≥ 8 days) from acute exacerbation of chronic bronchitis and COPD.
Anzueto A; Miravitlles M; Ewig S; Legnani D; Heldner S; Stauch K
Respir Med; 2012 Sep; 106(9):1258-67. PubMed ID: 22749710
[TBL] [Abstract][Full Text] [Related]
6. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
Blasi F; Schaberg T; Centanni S; Del Vecchio A; Rosignoli MT; Dionisio P
Pulm Pharmacol Ther; 2013 Oct; 26(5):609-16. PubMed ID: 23538168
[TBL] [Abstract][Full Text] [Related]
7. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
Beeh KM; Beier J; Candler H; Wittig T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of indacaterol 75 μg once daily in patients aged ≥40 years with chronic obstructive pulmonary disease: results from 2 double-blind, placebo-controlled 12-week studies.
Kerwin EM; Gotfried MH; Lawrence D; Lassen C; Kramer B
Clin Ther; 2011 Dec; 33(12):1974-84. PubMed ID: 22177371
[TBL] [Abstract][Full Text] [Related]
9. Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies.
El Moussaoui R; Roede BM; Speelman P; Bresser P; Prins JM; Bossuyt PM
Thorax; 2008 May; 63(5):415-22. PubMed ID: 18234905
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of OM-85 BV in COPD and chronic bronchitis: a systematic review.
Sprenkle MD; Niewoehner DE; MacDonald R; Rutks I; Wilt TJ
COPD; 2005 Mar; 2(1):167-75. PubMed ID: 17136978
[TBL] [Abstract][Full Text] [Related]
11. Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol/fluticasone.
Cazzola M; Noschese P; Di Perna F
Ther Adv Respir Dis; 2009 Apr; 3(2):59-63. PubMed ID: 19443519
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT study.
Miravitlles M; Anzueto A; Ewig S; Legnani D; Stauch K
Ther Adv Respir Dis; 2009 Dec; 3(6):267-77. PubMed ID: 19880426
[TBL] [Abstract][Full Text] [Related]
13. The immunostimulant OM-85 BV prevents wheezing attacks in preschool children.
Razi CH; Harmancı K; Abacı A; Özdemir O; Hızlı S; Renda R; Keskin F
J Allergy Clin Immunol; 2010 Oct; 126(4):763-9. PubMed ID: 20920766
[TBL] [Abstract][Full Text] [Related]
14. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
[TBL] [Abstract][Full Text] [Related]
15. Bronchodilatory effects of NVA237, a once daily long-acting muscarinic antagonist, in COPD patients.
Fogarty C; Hattersley H; Di Scala L; Drollmann A
Respir Med; 2011 Mar; 105(3):337-42. PubMed ID: 21144724
[TBL] [Abstract][Full Text] [Related]
16. [Influence of Broncho-Vaxom treatment on serum concentration of metalloproteinase-9 in patients with chronic obstructive pulmonary disease].
Targowski T; Jahnz-Rózyk K; Płusa T; Niedziałkowski P; Rozyńska R
Pol Merkur Lekarski; 2005 Nov; 19(113):630-3. PubMed ID: 16498799
[TBL] [Abstract][Full Text] [Related]
17. Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Miravitlles M; Llor C; Naberan K; Cots JM; Molina J;
Respir Med; 2005 Aug; 99(8):955-65. PubMed ID: 15950136
[TBL] [Abstract][Full Text] [Related]
18. Short-course fluoroquinolone therapy in exacerbations of chronic bronchitis and COPD.
Anzueto A; Miravitlles M
Respir Med; 2010 Oct; 104(10):1396-403. PubMed ID: 20580215
[TBL] [Abstract][Full Text] [Related]
19. Fluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitis.
Schermer T; Chavannes N; Dekhuijzen R; Wouters E; Muris J; Akkermans R; van Schayck O; van Weel C
Respir Med; 2009 Apr; 103(4):542-51. PubMed ID: 19138505
[TBL] [Abstract][Full Text] [Related]
20. Primary prevention of acute respiratory tract infections in children using a bacterial immunostimulant: a double-masked, placebo-controlled clinical trial.
Jara-Pérez JV; Berber A
Clin Ther; 2000 Jun; 22(6):748-59. PubMed ID: 10929921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
